Showing 1,181 - 1,200 results of 164,542 for search '(( 2 a decrease ) OR ( 5 ((((wt decrease) OR (mean decrease))) OR (we decrease)) ))', query time: 1.88s Refine Results
  1. 1181

    Reducing SIRT1 activity increases, and increasing SIRT1 expression decreases, mitochondrial enzymes in C<sub>2</sub>C<sub>12</sub> myotubes and rat skeletal muscle. by Kazuhiko Higashida (351645)

    Published 2013
    “…(D) Overexpression of wild-type (WT) SIRT1 in C<sub>2</sub>C<sub>12</sub> myotubes resulted in decreased cytochrome c protein expression and inhibited the resveratrol (RSV)-induced increase in cytochrome c. …”
  2. 1182
  3. 1183
  4. 1184
  5. 1185
  6. 1186
  7. 1187
  8. 1188
  9. 1189
  10. 1190
  11. 1191

    Deterioration of the anammox process at decreasing temperatures and long SRTs by Maaike Hoekstra (3915545)

    Published 2017
    “…The growth rate and specific anammox activity in the system decreased from 0.33 d<sup>−1</sup> and 4.47 g NO<sub>2</sub>-N g VSS<sup>−1</sup> d<sup>−1</sup> at 30°C to 0.0011 d<sup>−1</sup> and 0.037 g NO<sub>2</sub>-N g VSS<sup>−1</sup> d<sup>−1</sup> at 20°C. …”
  12. 1192
  13. 1193
  14. 1194

    Data_Sheet_1_Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.d... by Chantal C. Clark (10684632)

    Published 2021
    “…</p><p>Conclusion: We observed an association between the use of preexisting thromboprophylaxis and a decreased risk of TE during COVID-19. This suggests that these therapies are beneficial for coping with COVID-19 associated hypercoagulability. …”
  15. 1195
  16. 1196

    BC−/EC+ exhibited increased end-systolic and end-diastolic volume and decreased left ventricular function 3 weeks post MI. by Simone Gorressen (605474)

    Published 2015
    “…<p>BC−/EC+ exhibited an increase in end-systolic (<b>A</b>) and end-diastolic volume (<b>B</b>), a significantly more pronounced decrease in stroke volume (<b>C</b>) (BC+/EC+ n = 8 and BC−/EC+ n = 5; two-way ANOVA and Bonferroni’s post hoc test or student’s t-test; * p<0.05, ** p≤ 0.01 BC+/EC+ vs. …”
  17. 1197
  18. 1198

    DataSheet1_Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5−/− mice, decreases plasma cholesterol and epididymal fat deposition.PDF by Sunil Veeravalli (5074115)

    Published 2022
    “…Our results indicate a microbial contribution to the phenotypic characteristic of Fmo5<sup>−/−</sup> mice of decreased plasma cholesterol and identify 2,3-butanediol as a potential agent for lowering plasma cholesterol.…”
  19. 1199

    Expression of SPDEF in prostate adenocarcinoma cells decreased prostate carcinogenesis in orthotopic model. by Xin-Hua Cheng (154368)

    Published 2014
    “…Mean weights of prostate glands (±SD) are shown (n = 10 for control TRAMP C2 cells, n = 5 for SPDEF OE cells). …”
  20. 1200